Skip to content
2000
Volume 12, Issue 27
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Nitric oxide (NO) is a reactive radical produced by the enzyme nitric oxide synthase (NOS) and it plays an important role in a large number of biological pathways. NO can be produced under normal physiologic conditions and contribute to homeostasis but, when produced in excess, it may lead to tissue injury and organ dysfunction. The regulation of NOS activity and expression is becoming increasingly understood. NOS enzyme inhibitors as tools to decrease excessive NO synthesis have received the most attention and have been subjected to the greatest experimental study. Compounds that scavenge excessive NO have been developed and have shown promise in a number of experimental models but have received considerably less attention as potential therapeutic agents. In this article, the use of NO scavengers in two conditions in which excessive NO appears to be pathophysiologically significant, shock and sepsis, is reviewed. The relevant biology of NO in these disease states is presented and the therapeutic potential of NO scavengers in clinical care is explored.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161206778343000
2006-09-01
2025-05-05
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161206778343000
Loading

  • Article Type:
    Research Article
Keyword(s): Dithiocarbamate; endotoxin; hemorrhagic shock; iNOS; Polyaminocarborylate compounds
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test